Liver Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with liver cancer (HCC) that has not spread to the lymph nodes or other parts of the body.
• People who have previously had surgery or a radiofrequency ablation procedure to treat their liver cancer, with no signs of the cancer coming back within the first 6 months after that treatment.
• People whose liver cancer falls within specific size and spread limits: either one tumor smaller than 5 cm, or no more than three tumors each smaller than 3 cm, with no invasion into blood vessels and no spread outside the liver.
• People who have enough healthy liver tissue remaining outside the area being treated (more than 700 ml in volume).
• People who do not have serious problems with their blood, heart, lungs, liver, kidneys, or immune system.
• People whose blood test results meet the required levels for red blood cells, white blood cells, infection-fighting cells, and platelets (confirm with trial site for exact values).
• People who are able to have children and are willing to use contraception during the trial.
• People who are in a good general physical condition and have acceptable liver function, as measured by standard medical scoring tools (confirm with trial site).
• People who are expected to live for more than 3 months.
• People who are willing to take part voluntarily and sign a consent form.

Who may not be able to join:

• People who have already received anti-cancer treatment specifically for their liver cancer.
• People with significant liver scarring (cirrhosis), recent bleeding from the digestive tract related to liver pressure problems, or poor liver function scores.
• People whose liver function blood tests show certain levels are too high — specifically, bilirubin more than 1.5 times the normal upper limit, or two liver enzymes (ALT and AST) more than 2.5 times the normal upper limit, or a specific liver function test result of 40% or above (confirm with trial site).
• People who have had major surgery within one month before the study begins.
• People who have a history of another cancer, unless they had basal cell skin cancer or early-stage cervical cancer and have been cancer-free for more than 3 years after treatment.
• People who have taken part in another clinical trial within 30 days before this study's treatment begins.
• People whose tumor is located very close (less than 0.5 cm) to the stomach or intestines.
• People who are pregnant, breastfeeding, or able to have children but not willing to use contraception.
• People with a history of drug addiction, long-term heavy alcohol use, or HIV/AIDS.
• People with uncontrolled epileptic seizures or a mental illness that significantly affects their awareness or judgment.
• People with a history of severe allergic reactions or who are known to have unusual sensitivities (confirm with trial site).
• People whom the trial researchers consider unsuitable for participation for other reasons.

Important: Always verify eligibility with the trial site directly before applying.